期刊文献+

磺胺嘧啶银霜联合重组人粒细胞巨噬细胞刺激因子凝胶治疗深Ⅱ度烧伤创面的疗效评价 被引量:11

Evaluation of Therapeutic Effect of Recombinant Human Granulocyte-macrophage Colony-stimulating Factor Combined with SD-Ag Unguent on Deep Second Degree Burn
下载PDF
导出
摘要 目的通过调查分析评价重组人粒细胞巨噬细胞刺激因子(rh GM-CSF)凝胶联合应用磺胺嘧啶银(SDAg)霜对深Ⅱ度烧伤创面愈合的疗效。方法收集深Ⅱ度烧伤创面(总面积<10%)患者89例,按创面用药情况将患者分成A组(SD-Ag霜)和B组(rh GM-CSF凝胶+SD-Ag霜),观察比较两组创面愈合率、上皮化时间及不良反应。结果创面上皮化时间:A组、B组分别为(19.79±1.47),(15.76±1.63)d,B组显著短于A组;创面愈合率:伤后9,13,16,21 d创面愈合率A组、B组分别为(67.24±2.33)%,(75.54±1.11)%,(88.33±1.32)%,(99.14±1.95)%和(76.41±3.24)%,(95.01±1.43)%,(99.54±0.88)%,(100.00±0.00)%,组间同期比较B组均优于A组;治疗期间两组均未见明显不良反应。结论 SD-Ag霜联合外用rh GM-CSF凝胶剂能促进深Ⅱ度烧伤创面愈合,疗效确切安全。 Objective To evaluate the therapeutic effect of recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) combined with sulfadiazine sliver (SD-Ag) unguent on deep second degree burn. Methods Eighty-nine patients with deep second-degree burn (burns areas〈 10% ) were enrolled.These patients were divided into two groups at random (Group A and Group B).The patients in Group A were treated with SD-Ag unguent only, and those in Group B were treated with rhGM-CSF and SD-Ag unguent.The therapeutic effects and the adverse drug reaction were recorded. Results The healing time in Group A [ (19.79±1.47) days] was obviously shorter than that in Group B [ (15.76±1.63) days].The total wound healing rates in Group B [on day 9: (76.41±3.24)%, day 13: (95.01±1.43)%, day 16: (99.54±0.88)%, and day 21 (100.00±0.00)%] were higher than those of Group A [on day 9: (67.24±2.33)%, day 13: (75.54±1.11)%, day 16: (88.33±1.32) %, day 21: (99.14±1.95)% ].During the treatment, there was no obvious adverse reaction was observed in the two groups. Conclusion The application of rhGM-CSF combined with SD-Ag unguent can not only accelerate the healing rates of deep second-degree burn, but also has curative effect with safety.
出处 《医药导报》 CAS 2015年第12期1588-1590,共3页 Herald of Medicine
关键词 重组人粒细胞巨噬细胞刺激因子 磺胺嘧啶银 烧伤 深Ⅱ度 Recombinant human granulocyte-macrophage colony stimulating factor Sulfadiazine silver Bums, deep second degree
  • 相关文献

参考文献8

  • 1方勇,龚圣济,王莹,徐英华,包士三.单核细胞集落刺激因子缺失对小鼠创面愈合与新生血管化的影响[J].中华整形外科杂志,2007,23(3):233-235. 被引量:12
  • 2MIDDLETON M, THATCHER N. G- and GM-CSF [ J ]. Int J Antimicrobial Agents, 1998,10 ( 1 ) : 91.
  • 3BUSSOLINO F,WANG J M, DEFILIPPI P, et al.Granulocyte and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate [ J ]. Nature, 1989,337 (2) :471-473.
  • 4MANN A, BREUHAHN K, SCHIRNACHER P, et al. Kerati- nocyte-derived granulocyte-macrophage colony-stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization [ J ].J Invest D ermatol, 2001,117 (6) : 1382-1390.
  • 5FANG Y, GONG S J, XU Y H, et al. Impaired cutaneous wound healing in granulocyte-macrophage colony stimulating factor knockout mice [ J ]. Br J Dematol, 2007,157 ( 3 ) : 458- 465.
  • 6MANN A, NIEKISCH K, SCHIRNACHER P, et al. Granulo- cyte-macrophage colony-stimulating factor is essential for normal wound healing [ J ]. J Investig Dermatol Symp Proc, 2006,11 ( 1 ) : 87-92.
  • 7CIANFARANI F, TOMMASI R, Failla C M, et al. Granulo- cyte-macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed[ J] .Br J Dermatol, 2006,154( 1 ) :34-41.
  • 8王志勇,张勤,廖镇江,韩春茂,吕国忠,罗成群,陈炯,杨时昕,杨晓东,刘群.重组人粒细胞巨噬细胞集落刺激因子对深Ⅱ度烧伤创面的治疗作用[J].中华烧伤杂志,2008,24(2):107-110. 被引量:41

二级参考文献21

  • 1Mann A, Breuhahn K, Schirmacher P, et al. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization. J Invest Dermatol,2001 , 117 (6) : 1382-1390.
  • 2Jaschke E, Zabernigg A, Gattringer C. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int J Dermatol, 1999, 38(5) :380-386.
  • 3Masucci G. New clinical application of granulocyte-macrophage colony-stimulating factor. Med Oncol, 1996,13 (3) : 149-154.
  • 4Masucci G, Broman P, Kelly C, et al. Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a muhicenter open randomized phase Ⅲ study. Med Oneol, 2005,22 (3) :247-256.
  • 5Groves RW, Schmidt-Lucke JA. Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv Skin Wound Care, 2000 ,13(3) :107-112.
  • 6Fang Y, Gong SJ,Xu YH,et al. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice. Br J Dermatol, 2007,157 ( 3 ) :458-465.
  • 7Mann A, Niekisch K, Schirmacher P, et al. Granulocyte-macrophage colony-stimulating factor is essential for normal wound healing. J Investig Dermatol Symp Proc, 2006 , 11 ( 1 ) :87-92.
  • 8M Middleton, N Thatcher. G- and GM-CSF. Int J of Antimicrobial Agents, 1998,10: 91-92.
  • 9Kawada A, Hiruma M, Noguchi H, et al. Granulocyte and macrophage colony-stimulating factors stimulate proliferation of human keratinocytes. Arch Dermatol Res, 1997,289:600-602.
  • 10Hancock GE, Kaplan G, Cohn ZA. Keratinocyte growth regulation by the products of immune cells. J Exp Med, 1988,168:1395-1402.

共引文献50

同被引文献113

引证文献11

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部